Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
MIMOSA study aims to characterize from behavioral, neurophysiological and neurocognitive
perspectives children and adolescents with attention deficit hyperactivity disorder (ADHD),
in order to identify a possible biomarker of response to medication treatments. To achieve
this aim, in the study children with ADHD (drug naive) are recruited and undergo behavioral
and clinical screenings, neurocognitive profile, and neurophysiological evaluation with
functional near infrared spectroscopy (fNIRS). ADHD group is evaluated before the beginning
of medications, at first dose of medication (only imaging evaluation fNIRS), and after a
period of two/three months of continuous treatment with medication.